Organization Overview
Historical Acquisition Tree
Alternative names
empagliflozin (jardiance) (2020)
linagliptin (tradjenta) (2020)
Key: Syneos Health (0) Acquired (3)
Key: Syneos Health (23) Acquired (17)
albumin (Human) (Plasbumin) (1 trial)
Allogeneic bone marrow derived mesenchymal stromal cells (1 trial)
alpha-1 antitrypsin (Prolastin) (1 trial)
bnt162b2 (Comirnaty) (1 trial)
capecitabine (xeloda) (1 trial)
dasiglucagon (Zegalogue) (1 trial)
daxibotulinumtoxinA (Daxxify) (2 trials)
dimethyl fumarate (tecfidera) (1 trial)
irinotecan (Camptosar) (1 trial)
nitric oxide (inomax) (2 trials)
pembrolizumab (keytruda) (3 trials)
Key: Syneos Health (15) Acquired (34)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
bendamustine (treanda) (1 trial)
bortezomib (velcade) (1 trial)
brexanolone (Zulresso) (1 trial)
ceftazidime (fortaz) (1 trial)
depigold olea europea (1 trial)
entecavir (baraclude) (1 trial)
estetrol (NEXTSTELLIS) (1 trial)
fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)
fospropofol (lusedra) (1 trial)
Ibrexafungerp (Brexafemme) (1 trial)
inactivated influenza vaccine (1 trial)
inactivated rabies vaccine (Imovax) (1 trial)
Key: Syneos Health (40) Acquired (29)
abiraterone (zytiga) (1 trial)
acetylsalicylic acid (aspirin) (2 trials)
bupropion (wellbutrin) (5 trials)
crizotinib (xalkori) (1 trial)
enterococcus faecium (1 trial)
estradiol (progynon depot) (1 trial)
Filgrastim (neupogen) (1 trial)
fludarabine (fludara) (1 trial)
mefenamic acid (ponstel) (1 trial)
moxifloxacin (avelox) (1 trial)
nalbuphine (nubain) (2 trials)
nateglinide (starlix) (2 trials)
nebivolol (bystolic) (1 trial)
oxytocin (syntocinon) (1 trial)
peanut allergen (Palforzia) (1 trial)
recombinant norovirus hexavalent vaccine (1 trial)
sweet vernal, orchard, perennial rye, timothy, and kentucky blue grass mixed pollens allergen extract (Oralair) (1 trial)
tocilizumab (actemra) (1 trial)
tranylcypromine (parnate) (1 trial)
valproic acid (depakene) (1 trial)
vinorelbine (navelbine) (1 trial)
zika virus immune globulin (1 trial)
Key: Syneos Health (2) Acquired (4)
Acute Lung Injury (Phase 3)
alpha 1-Antitrypsin Deficiency (Phase 3)
Aspergillosis (Phase 2)
Clostridium Infections (Phase 2)
Coronary Disease (Phase 2)
Diabetic Neuropathies (Phase 2)
Dry Eye Syndromes (Phase 2)
Dystonia (Phase 3)
Dystonic Disorders (Phase 3)
Emphysema (Phase 2)
Eunuchism (Phase 3)
Eye Diseases (Phase 2)
Fibromyalgia (Phase 2)
Fibrosis (Phase 2)
Heart Diseases (Phase 3)
Hypertension (Phase 1)
Hypogonadism (Phase 3)
Idiopathic Pulmonary Fibrosis (Phase 2)
Infarction (Phase 2)
Invasive Pulmonary Aspergillosis (Phase 2)
Keratitis (Phase 2)
Keratoconjunctivitis Sicca (Phase 2)
Liver Diseases (Phase 1)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 2)
Melanoma (Phase 2)
Myocardial Infarction (Phase 2)
Myofascial Pain Syndromes (Phase 2)
Neuralgia (Phase 2)
Opioid-Related Disorders (Phase 1)
Peripheral Nervous System Diseases (Phase 2)
Pulmonary Aspergillosis (Phase 2)
Pulmonary Fibrosis (Phase 2)
Renal Insufficiency (Phase 1)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Respiratory Tract Diseases (Phase 3)
Respiratory Tract Infections (Phase 3)
ST Elevation Myocardial Infarction (Phase 2)
Torticollis (Phase 3)
Vascular Diseases (Phase 2)
Virus Diseases (Phase 1)
Zika Virus Infection (Phase 1)